The global biosurgery market is projected to reach $ 15.58 billion by 2023 from $ 11.36 billion in 2018, at a CAGR of 6.5%. The global biosurgery market is fragmented with various regional and multinational market players. In 2017, Baxter (US), Johnson & Johnson (J & J) (US), and Medtronic (Ireland) dominated the biosurgery market. These players together accounted for 55% -60% of the market share.
In 2017, Baxter dominated the global biosurgery market. The company has a strong presence across North America, Europe, the Middle East, Africa, and Asia Pacific. Nursing homes, kidney dialysis centers, clinical and medical research laboratories, rehabilitation centers, doctors‘ offices, and patients at home and physician supervision. The company’s strong manufacturing and distribution network across the globe has made it a strong foothold in the biosurgery market. Collaborations and product launches are some of the major strategies adopted by the company in order to grow in this market.
Download Free Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=166922302
Johnson & Johnson (J & J) held the second position in the global biosurgery market in 2017. The company offers its products through two of its subsidiaries, namely, Ethicon, Inc. (US) and DePuy Synthes (US). The major end users of the company’s products include physicians, nurses, clinics, and hospitals. Over the years, the company has established itself in North America, Europe, the Middle East and Africa, and Asia Pacific. The company has a wide product portfolio, which enables it to strengthen its presence in the biosurgery market. Like J & J, Ethicon also has a diverse product portfolio, and more than 600 general surgical products are listed in the US FDA. Most of these products have patent exclusivity in the US beyond 2020, which seeks to sustain the market position. Ethicon harnesses J & J’s worldwide infrastructure to sell its products. Ethicon thus gets benefited through synergies with its parent company in R & D, technology know-how, business strategies, and project implementation experience.
Medtronic (Ireland) Held the third position in the global biosurgery market in 2017. The company is a multinational medical technology company that manufactures and markets products for alleviating pain and restoring health. The company’s products are used by hospitals, clinics, third-party healthcare providers, distributors, and other institutions (including governmental healthcare programs and group purchasing organizations). Medtronic has a well-diversified business and strong geographic presence in the market. The company has a strong presence in the US market and is expanding its reach into emerging markets. For instance, in 2016, the company opened its regional headquarters in Singapore to improve its market presence in the Asia Pacific market. Medtronic offers soft-tissue attachment products through its subsidiary Covidien. Covidien offers synthetic monofilament meshes, composite meshes, and biologic meshes. The company also offers tack applicators for mesh fixation. Medtronic offers its mesh fixation tacks under the brand name ProTack.
Some of the other players operating in this market include Sanofi Group (France), B. Braun Melsungen AG (Germany), MAQUET Holding BV & Co. KG. (Germany), CryoLife, Inc. (US), Stryker Corporation (US), and Hemostasis, LLC. (US), Integra Lifesciences Holdings Corporation (US), Cohera Medical Inc. (US), Pfizer Inc. (US), CSL Limited (Australia).
Medical Devices Market Research Reports & Consulting
About MarketsandMarkets ™
MarketsandMarkets ™ provides quantified B2B research on 30,000 high growth opportunities / threats 70% to 80% of worldwide companies‘ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets ™ for their painpoints around
Our 850 fulltime analyst and SMEs at MarketsandMarkets ™ are following the „Growth Engagement Model – GEM“. The GEM aims to identify new opportunities, identify the most important customers, write attack, avoid and defend strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets ™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets ™ is going to spend more than 10,000 companies this year for their revenue planning and help them make their innovations / disruptions early to the market.
MarketsandMarkets‘ flagship competitive intelligence and market research platform, ‚Knowledge Store‘, joins over 200,000 markets and entire value chains for the understanding of the marketplace.
Contact:
Mr. Shelly Singh
MarketsandMarkets ™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: + 1-888-600-6441
Email: sales@marketsandmarkets.com